Nexus Surgical and Medicare Ltd
₹ 18.0
-5.00%
24 Jan
- close price
About
Incorporated in 1992, Nexus Surgical and Medicare Ltd deals in medical disposable, surgical equipment, pharmaceutical products[1]
Key Points
- Market Cap ₹ 9.88 Cr.
- Current Price ₹ 18.0
- High / Low ₹ 29.3 / 10.4
- Stock P/E 21.0
- Book Value ₹ 1.57
- Dividend Yield 0.00 %
- ROCE 65.9 %
- ROE 46.2 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 88.7%
Cons
- Stock is trading at 11.5 times its book value
- The company has delivered a poor sales growth of 10.2% over past five years.
- Promoter holding is low: 18.7%
- Debtor days have increased from 44.2 to 78.9 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.02 | 0.09 | 0.43 | 0.33 | 0.30 | 0.98 | 2.14 | 1.73 | 3.74 | 2.40 | 1.55 | 3.47 | 4.83 | |
| 0.00 | 0.01 | 0.21 | 0.25 | 0.48 | 1.36 | 2.32 | 1.66 | 3.58 | 2.03 | 1.33 | 3.20 | 4.20 | |
| Operating Profit | 0.02 | 0.08 | 0.22 | 0.08 | -0.18 | -0.38 | -0.18 | 0.07 | 0.16 | 0.37 | 0.22 | 0.27 | 0.63 |
| OPM % | 100.00% | 88.89% | 51.16% | 24.24% | -60.00% | -38.78% | -8.41% | 4.05% | 4.28% | 15.42% | 14.19% | 7.78% | 13.04% |
| 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.06 | 0.08 | -5.35 | 0.01 | 0.02 | 0.01 | 0.03 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Depreciation | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.00 | 0.07 | 0.22 | 0.07 | -0.19 | -0.32 | -0.10 | -5.28 | 0.17 | 0.39 | 0.23 | 0.29 | 0.63 |
| Tax % | 28.57% | 31.82% | 28.57% | 0.00% | 3.12% | 0.00% | 0.38% | 5.88% | 25.64% | 26.09% | 27.59% | ||
| 0.00 | 0.05 | 0.15 | 0.05 | -0.19 | -0.33 | -0.11 | -5.30 | 0.15 | 0.29 | 0.17 | 0.21 | 0.47 | |
| EPS in Rs | 0.00 | 0.09 | 0.27 | 0.09 | -0.35 | -0.60 | -0.20 | -9.69 | 0.27 | 0.53 | 0.31 | 0.38 | 0.85 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 44% |
| 5 Years: | 10% |
| 3 Years: | -2% |
| TTM: | 60% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 31% |
| 3 Years: | 12% |
| TTM: | 683% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -10% |
| 5 Years: | 7% |
| 3 Years: | 73% |
| 1 Year: | 47% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 89% |
| Last Year: | 46% |
Balance Sheet
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 |
| Reserves | 0.01 | 0.06 | 0.12 | 0.17 | 0.00 | -0.33 | -0.44 | -5.73 | -5.58 | -5.29 | -5.12 | -4.91 | -4.61 |
| 0.00 | 0.00 | 0.00 | 0.09 | 0.29 | 0.25 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.02 | 0.04 | 0.13 | 0.04 | 0.18 | 0.20 | 0.20 | 0.47 | 1.04 | 1.82 | 0.56 | 1.25 | 1.19 | |
| Total Liabilities | 5.50 | 5.57 | 5.72 | 5.77 | 5.94 | 5.59 | 5.49 | 0.21 | 0.93 | 2.00 | 0.91 | 1.81 | 2.05 |
| 0.15 | 0.13 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | |
| CWIP | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00 | 0.09 | 0.34 | 0.39 | 0.56 | 0.22 | 0.12 | 0.19 | 0.91 | 1.99 | 0.89 | 1.79 | 2.02 | |
| Total Assets | 5.50 | 5.57 | 5.72 | 5.77 | 5.94 | 5.59 | 5.49 | 0.21 | 0.93 | 2.00 | 0.91 | 1.81 | 2.05 |
Cash Flows
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.00 | 0.03 | -0.03 | -0.17 | -0.07 | 0.02 | 0.24 | 0.20 | -0.11 | 0.55 | -0.41 | |
| -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | |
| 0.00 | 0.00 | 0.00 | 0.09 | 0.20 | -0.04 | 0.01 | -0.26 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Cash Flow | -0.01 | 0.00 | 0.03 | 0.05 | 0.03 | -0.11 | 0.03 | -0.02 | 0.20 | -0.11 | 0.54 | -0.42 |
Ratios
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 324.44 | 152.79 | 254.39 | 292.00 | 37.24 | 6.82 | 0.00 | 11.71 | 0.00 | 9.42 | 78.89 |
| Inventory Days | 156.43 | 138.45 | 15.21 | 0.00 | 0.00 | 0.00 | 56.78 | 243.33 | ||||
| Days Payable | 104.29 | 226.55 | 72.24 | 454.22 | 754.33 | |||||||
| Cash Conversion Cycle | 0.00 | 324.44 | 152.79 | 306.54 | 203.90 | -19.79 | 6.82 | 0.00 | 11.71 | 0.00 | -388.03 | -432.11 |
| Working Capital Days | -182.50 | 243.33 | 152.79 | 276.52 | 279.83 | -7.45 | -22.17 | -73.84 | -43.92 | -19.77 | -77.71 | 29.45 |
| ROCE % | 0.00% | 1.27% | 3.96% | 1.41% | -3.13% | -5.74% | -1.87% | 2.78% | 1,114.29% | 86.79% | 65.93% |
Documents
Announcements
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 21St January, 2025 At 03:30 P.M. At The Registered Office Of The Company
21 Jan - Board approved unaudited financial results for Q3 2024.
-
Financial Results For The Quarter Ended 31St December, 2024
21 Jan - Board approved unaudited financial results for Q3 2024.
-
Board Meeting Intimation for Board Meeting Of Nexus Surgical And Medicare Limited Is Scheduled To Be Held On Tuesday, 21St January, 2025 At 03:30 P.M. At The Registered Office Of The Company
15 Jan - Board meeting to approve Q4 financial results.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
13 Jan - Submission of compliance certificate under Regulation 74(5).
-
Closure of Trading Window
30 Dec - Closure of trading window until financial results declaration.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
NSML is in the business of importing and marketing quality surgical and pharma products at economical prices. It holds all the necessary licenses / permissions for Import of above surgical consumables. The company is a wholesale dealer dealing in various sizes of disposal syringe (with and without needle) and pouches of various size used for storage of sterilized equipment and material.